QSAM Biosciences Kiemelkedően
Mi az QSAM Biosciences Kiemelkedően?
A Kiemelkedően az QSAM Biosciences, Inc. - 36.830M
Mi a Kiemelkedően meghatározása?
A fennálló részvények egy olyan vállalat vagy pénzügyi eszköz részvényei, amelyeket a befektetők engedélyeztek, bocsátottak ki és vásároltak meg.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Kiemelkedően a Health Care szektor a OTC-on cégekben a QSAM Biosciences -hoz képest
Mit csinál QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
kiemelkedően -hoz hasonló cégek QSAM Biosciences
- Dynagas LNG Partners LP nak Kiemelkedően 36.802M van
- Qualys Inc nak Kiemelkedően 36.811M van
- PDS Biotechnology nak Kiemelkedően 36.820M van
- Walker River Resources nak Kiemelkedően 36.827M van
- Canadian Orebodies nak Kiemelkedően 36.829M van
- Codiak BioSciences nak Kiemelkedően 36.830M van
- QSAM Biosciences nak Kiemelkedően 36.830M van
- Sleep Country Canada nak Kiemelkedően 36.837M van
- Nichols plc nak Kiemelkedően 36.855M van
- Tribune Publishing nak Kiemelkedően 36.874M van
- NAPCO Security Technologies Inc nak Kiemelkedően 36.874M van
- BlueCity nak Kiemelkedően 36.885M van
- Artson Engineering nak Kiemelkedően 36.920M van